Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-hodgkin lymphoma in a patient with esophageal cancer

Clinical Nuclear Medicine

Volumn 34, Issue 3, 2009, Pages 168-170

  Ahmadzadehfar, Hojjat ^a   Sabet, Amir ^a   Nake, Kristina ^a   Hinterthaner, Brigitte ^a   Biersack, Hans Jürgen ^a   Ezziddin, Samer ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Dual time point imaging; Esophageal cancer; F 18 FDG PET CT; Non hodgkin lymphoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

AGED; ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; EARLY CANCER; ESOPHAGEAL ADENOCARCINOMA; HUMAN; MALE; NONHODGKIN LYMPHOMA; ADENOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS TUMOR; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; TIME;

ADENOCARCINOMA; AGED; ESOPHAGEAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 66849109026     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318196754c     Document Type: Article

References (12)

1. Alkhawaldeh K, Bural G, Kumar R, et al. Impact of dual-time-point 18F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2008;35:246-252.
2. Conrad GR, Sinha P. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy. Nucl Med Commun. 2003;24:1129-1137.
3. Kumar R, Loving VA, Chauhan A, et al. Potential of dual-time-point imaging to improve breast cancer diagnosis with 18F-FDG PET. J Nucl Med. 2005;46:1819-1824.
4. Lan XL, Zhang YX, Wu ZJ, et al. The value of dual time point 18F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol 2008;63:756-764.
5. Matthies A, Hickeson M, Cuchiara A, et al. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. JNucl Med. 2002;43:871-875.
6. Mavi A, Urhan M, Yu JQ, et al. Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. JNucl Med. 2006;47:1440-1446.
7. Shen DH, Chang TH, Lin MH, etal. Dual-time-point PET/CT to differentiate fluorodeoxyglucose-avid hiatal hernia from mediastinal malignancy. Clin Nucl Med. 2006;31:492-496.
8. Xiu Y, Bhutani C, Dhurairaj T, et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med. 2007;32:101-105.
9. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. JNucl Med. 2001;42:1412-1417.
10. Zytoon AA, Murakami K, El-Kholy MR, et al. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT. Eur J Radiol. In press.
11. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorode- oxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur JNucl Med. 1999;26:1345-1348.
12. Zhuang H, Hustinx R, Alavi A. Effect of diazepam on the efficacy of dual-phase FDG PET imaging. Eur JNucl Med Mol Imaging. 2006;33:228- 229; author reply 230.